J T Schroeder1, A P Bieneman, K L Chichester, L Breslin, H Xiao, M C Liu. 1. The Department of Medicine, Divisions of Allergy and Clinical Immunology, Johns Hopkins Asthma and Allergy Center, 5501 Hopkins Bayview Circle, Baltimore, MD 21224, USA. schray@jhmi.edu
Abstract
BACKGROUND: Allergic inflammatory processes may have the capacity to propagate systemically through the actions of circulating leucocytes. Consequently, basophils from allergic individuals are often 'primed', as evidenced by their hyperresponsiveness in vitro. IFN-alpha secreted predominantly by plasmacytoid dendritic cells (pDCs), suppresses basophil priming for IL-13 production in vitro. OBJECTIVE: This study sought in vivo correlates arising during experimental allergen challenge that support an 'axis-interplay' between basophils and pDCs. METHODS: Using segmental allergen challenge (SAC) in the lung, the immune responses of both cell types from the blood were investigated in volunteers (n=10) before and 24 h after allergen exposure. These responses were then correlated with inflammatory parameters measured in bronchoalveolar lavage fluids (BALF). RESULTS: In the blood, SAC significantly augmented IL-13 secretion by basophils induced by IL-3 (P=0.009), yet reduced IFN-alpha secreted by pDCs stimulated with CpG (P=0.018). Both parameters were negatively correlated (P=0.0015), at least among those subjects that secreted the latter. Circulating basophil IL-13 responses further correlated with post-SAC bronchoalveolar lavage (BAL) parameters including IL-13 protein (P=0.04), basophil (P=0.051), eosinophil (P=0.0018), and total cell counts (P<0.003). Basophil and IL-13 levels in BAL correlated likewise (P=0.0002). CONCLUSIONS: These results support a mechanism of immune regulation whereby an allergen reduces innate immune responses and IFN-alpha production by pDCs, resulting in an enhanced inflammation and basophil cytokine production at sites of allergen exposure.
BACKGROUND:Allergic inflammatory processes may have the capacity to propagate systemically through the actions of circulating leucocytes. Consequently, basophils from allergic individuals are often 'primed', as evidenced by their hyperresponsiveness in vitro. IFN-alpha secreted predominantly by plasmacytoid dendritic cells (pDCs), suppresses basophil priming for IL-13 production in vitro. OBJECTIVE: This study sought in vivo correlates arising during experimental allergen challenge that support an 'axis-interplay' between basophils and pDCs. METHODS: Using segmental allergen challenge (SAC) in the lung, the immune responses of both cell types from the blood were investigated in volunteers (n=10) before and 24 h after allergen exposure. These responses were then correlated with inflammatory parameters measured in bronchoalveolar lavage fluids (BALF). RESULTS: In the blood, SAC significantly augmented IL-13 secretion by basophils induced by IL-3 (P=0.009), yet reduced IFN-alpha secreted by pDCs stimulated with CpG (P=0.018). Both parameters were negatively correlated (P=0.0015), at least among those subjects that secreted the latter. Circulating basophil IL-13 responses further correlated with post-SAC bronchoalveolar lavage (BAL) parameters including IL-13 protein (P=0.04), basophil (P=0.051), eosinophil (P=0.0018), and total cell counts (P<0.003). Basophil and IL-13 levels in BAL correlated likewise (P=0.0002). CONCLUSIONS: These results support a mechanism of immune regulation whereby an allergen reduces innate immune responses and IFN-alpha production by pDCs, resulting in an enhanced inflammation and basophil cytokine production at sites of allergen exposure.
Authors: A C Redrup; B P Howard; D W MacGlashan; A Kagey-Sobotka; L M Lichtenstein; J T Schroeder Journal: J Immunol Date: 1998-02-15 Impact factor: 5.422
Authors: M C Liu; W C Hubbard; D Proud; B A Stealey; S J Galli; A Kagey-Sobotka; E R Bleecker; L M Lichtenstein Journal: Am Rev Respir Dis Date: 1991-07
Authors: W J Lie; M J Van Der Veen; E F Knol; F P Mul; H M Jansen; D Roos; J S Van Der Zee Journal: Clin Exp Allergy Date: 2000-06 Impact factor: 5.018
Authors: John T Schroeder; Anja P Bieneman; Huiqing Xiao; Kristin L Chichester; Kavitha Vasagar; Sarbjit Saini; Mark C Liu Journal: J Immunol Date: 2005-11-01 Impact factor: 5.422
Authors: Shabnam Foroughi; Barbara Foster; Nayoung Kim; Leigh B Bernardino; Linda M Scott; Robert G Hamilton; Dean D Metcalfe; Peter J Mannon; Calman Prussin Journal: J Allergy Clin Immunol Date: 2007-09 Impact factor: 10.793
Authors: D Hober; S Benyoucef; W Chehadeh; V Chieux; X De La Tribonniere; Y Mouton; L Bocket; P Wattre Journal: Scand J Immunol Date: 1998-10 Impact factor: 3.487